{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T05:05:45Z","timestamp":1726290345263},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,15]]},"DOI":"10.7759\/cureus.17206","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T02:45:10Z","timestamp":1629081910000},"source":"Crossref","is-referenced-by-count":1,"title":["Non-Articular Felty Syndrome Refractory to Granulocyte Colony-Stimulating Factor Therapy"],"prefix":"10.7759","author":[{"given":"Hasham","family":"Saeed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidinma","family":"Ejikeme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Tucktuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qirat","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2004.05.002","article-title":"Felty's syndrome","volume":"18","author":"Balint GP","year":"2004","unstructured":"Balint GP, Balint PV. Felty's syndrome. Best Pract Res Clin Rheumatol. 2004, 18:631-45. 10.1016\/j.berh.2004.05.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-2-206","article-title":"Felty's syndrome as an initial presentation of rheumatoid arthritis: a case report","volume":"2","author":"Chavalitdhamrong D","year":"2009","unstructured":"Chavalitdhamrong D, Molovic-Kokovic A, Iliev A. Felty's syndrome as an initial presentation of rheumatoid arthritis: a case report. Cases J. 2009, 2:206. 10.1186\/1757-1626-2-206","journal-title":"Cases J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1874312901408010129","article-title":"Felty\u2019s syndrome, insights and updates","volume":"8","author":"Owlia MB","year":"2014","unstructured":"Owlia MB, Newman K, Akhtari M. Felty\u2019s syndrome, insights and updates. Open Rheumatol J. 2014, 8:129-36. 10.2174\/1874312901408010129","journal-title":"Open Rheumatol J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.10497","article-title":"Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus","volume":"46","author":"Hellmich B","year":"2002","unstructured":"Hellmich B, Csernok E, Schatz H, Gross WL, Schnabel A. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Arthritis Rheum. 2002, 46:2384-91. 10.1002\/art.10497","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225359","article-title":"Neutropaenia and splenomegaly without arthritis: think rheumatoid arthritis","volume":"2018","author":"Aslam F","year":"2018","unstructured":"Aslam F, Cheema RS, Feinstein M, Chang-Miller A. Neutropaenia and splenomegaly without arthritis: think rheumatoid arthritis. BMJ Case Rep. 2018, 2018:bcr2018225359. 10.1136\/bcr-2018-225359","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32834760fb","article-title":"The spectrum of large granular lymphocyte leukemia and Felty's syndrome","volume":"18","author":"Liu X","year":"2011","unstructured":"Liu X, Loughran TP Jr. The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Curr Opin Hematol. 2011, 18:254-9. 10.1097\/MOH.0b013e32834760fb","journal-title":"Curr Opin Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/BF00180001","article-title":"GM-CSF and G-CSF in Felty's syndrome","volume":"71","author":"Wagner DR","year":"1993","unstructured":"Wagner DR, Combe C, Gresser U. GM-CSF and G-CSF in Felty's syndrome. Clin Investig. 1993, 71:168-71. 10.1007\/BF00180001","journal-title":"Clin Investig"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0268-960x(96)90024-7","article-title":"Treatment of the neutropenia of Felty syndrome","volume":"10","author":"Rashba EJ","year":"1996","unstructured":"Rashba EJ, Rowe JM, Packman CH. Treatment of the neutropenia of Felty syndrome. Blood Rev. 1996, 10:177-84. 10.1016\/s0268-960x(96)90024-7","journal-title":"Blood Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.01.006","article-title":"Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus","volume":"10","author":"Newman KA","year":"2011","unstructured":"Newman KA, Akhtari M. Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus. Autoimmun Rev. 2011, 10:432-7. 10.1016\/j.autrev.2011.01.006","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-0218-5_20","article-title":"Neutropenias in Felty\u2019s syndrome and systemic lupus erythematosus","author":"Akhtari M","year":"2012","unstructured":"Akhtari M, Waller EK. Neutropenias in Felty\u2019s syndrome and systemic lupus erythematosus. Twenty Years of G-CSF. Milestones in Drug Therapy. Molineux G, Foote M, Arvedson T (ed): Springer, Basel, Switzerland; 2012. 1:381-91. 10.1007\/978-3-0348-0218-5_20"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320212","article-title":"Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG","volume":"32","author":"Fiechtner JJ","year":"1989","unstructured":"Fiechtner JJ, Miller DR, Starkebaum G. Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG. Arthritis Rheum. 1989, 32:194-201. 10.1002\/anr.1780320212","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.08.008","article-title":"Biological agents in the management of Felty's syndrome: a systematic review","volume":"41","author":"Narv\u00e1ez J","year":"2012","unstructured":"Narv\u00e1ez J, Domingo-Domenech E, G\u00f3mez-Vaquero C, et al.. Biological agents in the management of Felty's syndrome: a systematic review. Semin Arthritis Rheum. 2012, 41:658-68. 10.1016\/j.semarthrit.2011.08.008","journal-title":"Semin Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-0172(99)80040-7","article-title":"Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor","volume":"29","author":"Hellmich B","year":"1999","unstructured":"Hellmich B, Schnabel A, Gross WL. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Semin Arthritis Rheum. 1999, 29:82-99. 10.1016\/s0049-0172(99)80040-7","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/91.1.49","article-title":"Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF)","volume":"91","author":"Stanworth SJ","year":"1998","unstructured":"Stanworth SJ, Bhavnani M, Chattopadhya C, Miller H, Swinson DR. Treatment of Felty's syndrome with the haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF). QJM. 1998, 91:49-56. 10.1093\/qjmed\/91.1.49","journal-title":"QJM"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90363-6","article-title":"Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis","volume":"71","author":"Shoenfeld Y","year":"1981","unstructured":"Shoenfeld Y, Gurewich Y, Gallant LA, Pinkhas J. Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am J Med. 1981, 71:773-8. 10.1016\/0002-9343(81)90363-6","journal-title":"Am J Med"},{"key":"ref16","article-title":"The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. III. Effects on immune and inflammatory indices in synovial fluid","volume":"15","author":"Smith MD","year":"1988","unstructured":"Smith MD, Ahern MJ, Brooks PM, Roberts-Thomson PJ. The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. III. Effects on immune and inflammatory indices in synovial fluid. J Rheumatol. 1988, 15:238-41.","journal-title":"J Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105721","article-title":"Leukokinetic studies. 13. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis","volume":"47","author":"Bishop CR","year":"1968","unstructured":"Bishop CR, Athens JW, Boggs DR, Warner HR, Cartwright GE, Wintrobe MM. Leukokinetic studies. 13. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis. J Clin Invest. 1968, 47:249-60. 10.1172\/JCI105721","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000175","article-title":"A beneficial long-term and consistent response to rituximab in the treatment of refractory neutropenia and arthritis in a patient with Felty syndrome","volume":"20","author":"Sarp U","year":"2014","unstructured":"Sarp U, Ataman S. A beneficial long-term and consistent response to rituximab in the treatment of refractory neutropenia and arthritis in a patient with Felty syndrome. J Clin Rheumatol. 2014, 20:398. 10.1097\/RHU.0000000000000175","journal-title":"J Clin Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1932.02740670035010","article-title":"Effect of splenectomy in Felty's syndrome","volume":"99","author":"Hanrahan EM","year":"1932","unstructured":"Hanrahan EM, Miller SR. Effect of splenectomy in Felty's syndrome. JAMA. 1932, 99:1247-9. 10.1001\/jama.1932.02740670035010","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66737-non-articular-felty-syndrome-refractory-to-granulocyte-colony-stimulating-factor-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:14Z","timestamp":1707507254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66737-non-articular-felty-syndrome-refractory-to-granulocyte-colony-stimulating-factor-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.17206","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,15]]}}}